Retraction
Silencing of p68 and STAT3 synergistically diminishes cancer progression
Paper Information
Record ID:
54071
Author(s):
Journal:
Publication Date:
March 03, 2020
Retraction Date:
June 05, 2024
(1.5 year years ago)
Subjects:
Institutions:
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Chemical and Materials Engineering, The University of Alabama in Huntsville, AL 35899, USA
- Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, USA
- Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1714614411, Iran
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
- Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Countries:
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.lfs.2024.122772Additional Notes:
see also: https://pubpeer.com/publications/A21274781B2C269CC8FA92415ADBB2#1
Citations (34)
34
Total Citations3
Post-Retraction(8.8%)
31
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
210
Days since retraction (latest)
Simultaneous blockade of the <scp>CD73</scp>/<scp>EGFR</scp> axis inhibits tumor growth
Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa et al. (5 authors)
IUBMB Life
Published: Jan 2025
2 citations
2 citations
210 days after retraction
Intestinal probiotic-based nanoparticles for cytotoxic siRNA delivery in immunotherapy against cancer
Manfang Zhu, Xiaohua Chen, Yueyang Zhang et al. (6 authors)
International Journal of Pharmaceutics
Published: Sep 2024
2 citations
2 citations
100 days after retraction
Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy
Huiping Wang, Wenke Jin, Zixiang Li et al. (6 authors)
Drug Discovery Today
Published: Aug 2024
3 citations
3 citations
84 days after retraction
Nanomedicine Strategies for Targeting Tumor Stroma
Mei‐Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju et al. (4 authors)
Cancers
Open Access
Published: Aug 2023
12 citations
12 citations
293 days before retraction
RNA binding protein DDX5 restricts RORγt <sup>+</sup> T <sub>reg</sub> suppressor function to promote intestine inflammation
Shengyun Ma, Qiyuan Yang, Nicholas Chen et al. (15 authors)
Science Advances
Open Access
Published: Feb 2023
9 citations
9 citations
490 days before retraction
Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium
Peter J. Polverini, Felipe Nör, Jacques E. Nör
Frontiers in Oral Health
Open Access
Published: Jan 2023
7 citations
7 citations
512 days before retraction
Transcription Factor FXR Activates DHRS9 to Inhibit the Cell Oxidative Phosphorylation and Suppress Colon Cancer Progression
Jinlai Zhao, Yigang Wang, Yang Wang et al. (7 authors)
Analytical Cellular Pathology
Open Access
Published: Oct 2022
9 citations
9 citations
588 days before retraction
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
Junqing Gan, Shan Liu, Yu Zhang et al. (24 authors)
Experimental & Molecular Medicine
Open Access
Published: Aug 2022
42 citations
42 citations
645 days before retraction
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi et al. (17 authors)
Pharmaceutical Research
Published: Jun 2022
10 citations
10 citations
719 days before retraction
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Ali Zarrabi, Anupam Bishayee, Sepideh Mirzaei et al. (13 authors)
Current Molecular Pharmacology
Published: Apr 2022
17 citations
17 citations
779 days before retraction
DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer
Shaheda Tabassum, Mrinal K. Ghosh
Genes & Diseases
Open Access
Published: Mar 2022
9 citations
9 citations
807 days before retraction
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Xiaojuan Zhang, Chuanchuan He, Guangya Xiang
Cancer Letters
Published: Jan 2022
21 citations
21 citations
872 days before retraction
RETRACTED: Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli et al. (19 authors)
Life Sciences
Published: Nov 2021
22 citations
22 citations
928 days before retraction
Nanoparticles as a Therapeutic Approach for Tumor Angiogenesis
Abdullah A. A. Alghamdi, Amr Ahmed WalyEldeen, Sherif Ibrahim
Advances in medical technologies and clinical practice book series
Published: Oct 2021
2 citations
2 citations
953 days before retraction
Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer
Erva Özkan, Filiz Bakar‐Ates
Current Medicinal Chemistry
Published: Aug 2021
38 citations
38 citations
1030 days before retraction
Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer
Sima Emadi Allahyari, Farnaz Hajizadeh, Angelina Olegovna Zekiy et al. (15 authors)
Nanomedicine Nanotechnology Biology and Medicine
Published: Mar 2021
19 citations
19 citations
1169 days before retraction
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli et al. (14 authors)
Life Sciences
Published: Mar 2021
38 citations
38 citations
1174 days before retraction
Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth
Hendrik Setia Budi, Sepideh Izadi, Anton Timoshin et al. (16 authors)
Nanomedicine Nanotechnology Biology and Medicine
Open Access
Published: Mar 2021
27 citations
27 citations
1191 days before retraction
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
Milad Ashrafizadeh, Mohammad Gholami, Sepideh Mirzaei et al. (12 authors)
Life Sciences
Published: Jan 2021
70 citations
70 citations
1245 days before retraction
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi et al. (15 authors)
SSRN Electronic Journal
Published: Jan 2021
1251 days before retraction
Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Shima Bastaki, A. Surendar, Nasrin Ahmadpour Saheb et al. (16 authors)
Life Sciences
Published: Dec 2020
70 citations
70 citations
1274 days before retraction
The multifaceted functions of RNA helicases in the adaptive cellular response to hypoxia: From mechanisms to therapeutics
Yijie Wang, Guangqiang Li, Mingxia Deng et al. (8 authors)
Pharmacology & Therapeutics
Published: Dec 2020
13 citations
13 citations
1275 days before retraction
Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells
Vahid Karpisheh, Javad Fakkari Afjadi, Mohsen Nabi‐Afjadi et al. (15 authors)
International Journal of Biological Macromolecules
Published: Nov 2020
41 citations
41 citations
1293 days before retraction
Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth
Khalid Odamizil Alzamely, Farnaz Hajizadeh, Morteza Heydari et al. (14 authors)
Colloids and Surfaces B Biointerfaces
Published: Oct 2020
26 citations
26 citations
1326 days before retraction
RETRACTED ARTICLE: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry et al. (17 authors)
Pharmaceutical Research
Published: Sep 2020
50 citations
50 citations
1357 days before retraction
RETRACTED: Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
Shahin Hallaj, Sima Heydarzadeh Asl, Fatemeh Alian et al. (13 authors)
Life Sciences
Published: Jul 2020
25 citations
25 citations
1410 days before retraction
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Maryam Esmaily, Ali Masjedi, Shahin Hallaj et al. (14 authors)
Journal of Controlled Release
Published: Jun 2020
68 citations
68 citations
1445 days before retraction
Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression
Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani et al. (15 authors)
European Journal of Pharmacology
Published: Jun 2020
64 citations
64 citations
1446 days before retraction
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Ali Masjedi, Armin Ahmadi, Sepideh Ghani et al. (14 authors)
Nanomedicine Nanotechnology Biology and Medicine
Published: Jun 2020
39 citations
39 citations
1451 days before retraction
Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses
Mitra Ghasemi‐Chaleshtari, Seyed Hossein Kiaie, Mahzad Irandoust et al. (16 authors)
Journal of Cellular Physiology
Published: Jun 2020
37 citations
37 citations
1464 days before retraction
RETRACTED: Coinhibition of S1PR1 and GP130 by siRNA‐loaded alginate‐conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells
Narges Rostami, Afshin Nikkhoo, Yalda Khazaei‐Poul et al. (16 authors)
Journal of Cellular Physiology
Published: May 2020
25 citations
25 citations
1479 days before retraction
How microRNAs affect the PD-L1 and its synthetic pathway in cancer
Gholamreza Rezaei Danbaran, Saeed Aslani, Nadia Sharafkandi et al. (9 authors)
International Immunopharmacology
Published: May 2020
23 citations
23 citations
1485 days before retraction
Nanomedicine for improvement of dendritic cell-based cancer immunotherapy
Vida Hashemi, Shohreh Farhadi, Mitra Ghasemi Chaleshtari et al. (11 authors)
International Immunopharmacology
Published: Mar 2020
38 citations
38 citations
1527 days before retraction
Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression
Afshin Nikkhoo, Narges Rostami, Shohreh Farhadi et al. (14 authors)
International Journal of Pharmaceutics
Published: Mar 2020
74 citations
74 citations
1528 days before retraction
Quick Stats
Total Citations:
34
Years Since Retraction:
1.5 year
Open Access:
Yes
Last Checked:
Jul 24, 2025